J Korean Neurosurg Soc.  2018 Sep;61(5):633-639. 10.3340/jkns.2017.0238.

Repeat Stereotactic Radiosurgery for Recurred Metastatic Brain Tumors

• Kim IY
• Jung S
• Jung TY
• Moon KS
• Jang WY
• Park JY
• Song TW
• Lim SH

• KMID: 2420072
• DOI: http://doi.org/10.3340/jkns.2017.0238

Abstract

OBJECTIVE
We investigated the outcomes of repeat stereotactic radiosurgery (SRS) for metastatic brain tumors that locally recurred despite previous SRS, focusing on the tumor control.
METHODS
A total of 114 patients with 176 locally recurring metastatic brain tumors underwent repeat SRS after previous SRS. The mean age was 59.4 years (range, 33 to 85), and there were 68 male and 46 female patients. The primary cancer types were non-small cell lung cancer (n=67), small cell lung cancer (n=12), gastrointestinal tract cancer (n=15), breast cancer (n=10), and others (n=10). The number of patients with a single recurring metastasis was 95 (79.8%), and another 19 had multiple recurrences. At the time of the repeat SRS, the mean volume of the locally recurring tumors was 5.94 mL (range, 0.42 to 29.94). We prescribed a mean margin dose of 17.04 Gy (range, 12 to 24) to the isodose line at the tumor border primarily using a 50% isodose line.
RESULTS
After the repeat SRS, we obtained clinical and magnetic resonance imaging follow-up data for 84 patients (73.7%) with a total of 108 tumors. The tumor control rate was 53.5% (58 of the 108), and the median and mean progression-free survival (PFS) periods were 246 and 383 days, respectively. The prognostic factors that were significantly related to better tumor control were prescription radiation dose of 16 Gy (p=0.000) and tumor volume less than both 4 mL (p=0.001) and 10 mL at the repeat SRS (p=0.008). The overall survival (OS) periods for all 114 patients after repeat SRS varied from 1 to 56 months, and median and mean OS periods were 229 and 404 days after the repeat SRS, respectively. The main cause of death was systemic problems including pulmonary dysfunction (n=58, 51%), and the identified direct or suspected brain-related death rate was around 20%.
CONCLUSION
The tumor control following repeat SRS for locally recurring metastatic brain tumors after a previous SRS is relatively lower than that for primary SRS. However, both low tumor volume and high prescription radiation dose were significantly related to the tumor control following repeat SRS for these tumors after previous SRS, which is a general understanding of primary SRS for metastatic brain tumors.

Keyword

Metastasis; Gamma knife radiosurgery; Radiation therapy; Recurrence; Stereotactic radiosurgery

MeSH Terms

Brain Neoplasms*
Brain*
Breast Neoplasms
Carcinoma, Non-Small-Cell Lung
Cause of Death
Disease-Free Survival
Female
Follow-Up Studies
Gastrointestinal Neoplasms
Humans
Magnetic Resonance Imaging
Male
Mortality
Neoplasm Metastasis
Prescriptions
Radiosurgery*
Recurrence
Small Cell Lung Carcinoma
Tumor Burden

Reference

References

1. Ammirati M, Cobbs CS, Linskey ME, Paleologos NA, Ryken TC, Burri SH, et al. The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 96:85–96. 2010.

2. Baschnagel AM, Meyer KD, Chen PY, Krauss DJ, Olson RE, Pieper DR, et al. Tumor volume as a predictor of survival and local control in patients with brain metastases treated with gamma knife surgery. J Neurosurg. 119:1139–1144. 2013.

3. Chen JC, Petrovich Z, Giannotta SL, Yu C, Apuzzo ML. Radiosurgical salvage therapy for patients presenting with recurrence of metastatic disease to the brain. Neurosurg. 46:860–866. discussion 866-867. 2000.

4. Cho KR, Lee MH, Kong DS, Seol HJ, Nam DH, Sun JM, et al. Outcome of gamma knife radiosurgery for metastatic brain tumors derived from non-small cell lung cancer. J Neurooncol. 125:331–338. 2015.

5. Jensen CA, Chan MD, McCoy TP, Bourland JD, deGuzman AF, Ellis TL, et al. Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis. J Neurosurg. 114:1585–1591. 2011.

6. Kwon KY, Kong DS, Lee JI, Nam DH, Park K, Kim JH. Outcome of repeated radiosurgery for recurrent metastatic brain tumors. Clin Neurol Neurosurg. 109:132–137. 2007.

7. Lucas JT Jr, Colmer HG 4th, White L, Fitzgerald N, Isom S, Bourland JD, et al. Competing risk analysis of neurologic versus nonneurologic death in patients undergoing radiosurgical salvage after whole-brain radiation therapy failure: who actually dies of their brain metastases? Int J Radat Oncol Biol Phys. 92:1008–1015. 2015.

8. Mariya Y, Sekizawa G, Matsuoka Y, Seki H, Sugawara T, Sasaki Y. Repeat stereotactic radiosurgery in the management of brain metastases from non-small cell lung cancer. Tohoku J Exp Med. 223:125–131. 2011.

9. Marvaso G, Barone A, Vaccaro C, Bruzzaniti V, Grespi S, Scotti V, et al. Repeat stereotactic radiosurgery in the management of brain metastases from NSCLC: a case report and review of the literature. Oncol Lett. 6:897–900. 2013.

10. McKay WH, McTyre ER, Okoukoni C, Alphonse-Sullivan NK, Ruiz J, Munley MT, et al. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery. J Neurosurg. 127:148–156. 2017.

11. Shuto T, Fujino H, Inomori S, Nagano H. Repeated gamma knife radiosurgery for multiple metastatic brain tumours. Acta Neurochirurg (Wien). 146:989–993. discussion 993. 2004.

12. Sperduto PW, Wang M, Robins HI, Schell MC, Werner-Wasik M, Komaki R, et al. A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320. Int J Radat Oncol Biol Phys. 85:1312–1318. 2013.

13. Yamamoto M, Serizawa T, Shuto T, Akabane A, Higuchi Y, Kawagishi J, et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol. 15:387–395. 2014.

14. Yamanaka K, Iwai Y, Yasui T, Nakajima H, Komiyama M, Nishikawa M, et al. Gamma knife radiosurgery for metastatic brain tumor: the usefulness of repeated gamma knife radiosurgery for recurrent cases. Stereotact Funct Neurosurg. 72 Suppl 1:73–80. 1999.